Your mission
- Analyse perturbation and CRISPR screening data to resolve how a targeted epigenetic perturbation impacts gene activity.
- Curate, integrate and interpret multi-modal (epi)genomics data: chromatin accessibility, DNA methylation, histone modifications, 3D contacts and matched expression profiles, analysed within robust, reproducible genomics workflows.
- Build the pan-Epitome data archive from scratch: a searchable, version-controlled resource that becomes the training substrate for every model we deploy.
- Generate and test hypotheses on gene regulatory mechanisms - which elements control which genes, in which cell context, and how durably a locus can be rewired. Lay the building blocks for predictive modelling.
- Present findings to the team, leadership and external partners, and help define our computational and data strategy.
Your profile
- MSc or PhD in computational biology, bioinformatics, (epi)genomics, machine learning or a related field. Postdoctoral and/or industry experience is valued but not necessary — we hire on demonstrated ability, not title.
- Strong coding skills (Python and/or R) and a track record of running high-throughput analyses end to end: PyTorch or equivalent, version control, workflow managers (Nextflow, Snakemake) and cloud or HPC compute.
- Experience training, evaluating and interpreting machine learning models on biological data. Familiarity with sequence-to-function models (Enformer/AlphaGenome-type architectures) and with gene regulation is a strong plus, but not a requirement.
- Hands-on experience with perturbation screening or single-cell data (CRISPR screen, single-cell multiome, Perturb-seq) and/or (epi)genomics data (ChIP-seq, EM-seq etc) is beneficial.
- Excellent problem-solving, prioritisation and communication skills, and the ability to work closely with experimentalists.
- A flexible, entrepreneurial spirit - comfortable moving fast and adapting as we grow.
Why us?
- See your models and the company foundations you build act on the world: predictions here translate into edits, into programmes, and ultimately into therapies for diseases driven by gene regulation.
- Work with data that does not exist anywhere else. Our epigenome editing platform generates causal, targeted perturbations of chromatin state, giving your models the ground truth that purely observational genomics lacks.
- Work in Vienna, a global hub for life sciences and one of the world’s most liveable cities.
- Collaborate with a passionate, multidisciplinary team tackling some of the most exciting frontiers in CRISPR applications.
- Competitive compensation and benefits package.
About us
Epitome Therapeutics is an early-stage biotechnology company based in Vienna, Austria, and a spin-off of EMBL, Europe’s leading life science institution. Our proprietary platform, CADENCE, uses precision epigenome editing to durably activate gene expression without changing the underlying DNA sequence, opening the door to a new class of medicines for diseases driven by gene regulation.
Backed by an oversubscribed €4 million pre-seed round, we are building a small, multidisciplinary team that brings together bold ideas, cutting-edge tools and a collaborative spirit. Join us at the leading edge of CRISPR therapeutics.